EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 -0.6346
March 31, 2026 -0.7056
December 31, 2025 -0.5046
September 30, 2025 -0.4344
June 30, 2025 -0.3566
March 31, 2025 -0.0198
December 31, 2024 -0.5198
September 30, 2024 -0.0386
June 30, 2024 -0.0329
March 31, 2024 -0.0307
December 31, 2023 -0.0324
September 30, 2023 -0.0407
June 30, 2023 -0.036
March 31, 2023 -0.0018
December 31, 2022 -0.0133
September 30, 2022 -0.1278
June 30, 2022 -0.0329
March 31, 2022 -0.0295
December 31, 2021 0.1888
September 30, 2021 0.0738
June 30, 2021 -0.4175
March 31, 2021 -0.685
December 31, 2020 -0.4347
Date Value
September 30, 2020 -0.099
June 30, 2020 -0.0341
March 31, 2020 -0.209
December 31, 2019 -0.175
September 30, 2019 -0.0989
June 30, 2019 -0.1756
March 31, 2019 -0.1659
December 31, 2018 -0.0414
September 30, 2018 -0.1808
June 30, 2018 -4.684
March 31, 2018 -0.16
December 31, 2017 -0.12
September 30, 2017 -0.13
June 30, 2017 -0.12
March 31, 2017 -0.14
December 31, 2016 -0.11
September 30, 2016 -0.12
June 30, 2016 -0.13
March 31, 2016 -0.15
December 31, 2015 -0.40
September 30, 2015 0.00
December 31, 2014 -0.0209
September 30, 2014 -0.0002

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Electromed, Inc. 0.3894
Tandem Diabetes Care, Inc. -0.3067
Accuray, Inc. -0.0154
Micron Solutions, Inc. --
IDEXX Laboratories, Inc. 4.267